Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Interleukin 6 Receptor Antagonists [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0024-5908 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5910 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5920 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5922 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
50242-135 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-136 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-137 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-138 Actemra tocilizumab Genentech, Inc. INJECTION, SOLUTION 2013-10-21
50242-143 Actemra ACTPen tocilizumab Genentech, Inc. INJECTION, SOLUTION 2018-11-19
64406-022 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
64406-023 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
64406-024 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
65219-590 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
65219-592 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
65219-594 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
72606-042 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-043 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-044 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-045 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-048 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-049 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-050 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-051 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
78206-200 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03
78206-201 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03
78206-202 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03

 Mechanism of Action Classification 

Loading full table content...